Commissioner Of Food And Drug Administration Announces He Will Resign

In a surprise move, the Food and Drug Administration commissioner announced Tuesday he will resign from his position. Dr. Scott Gottlieb is widely viewed as an effective advocate of public health. </s> Food and Drug Administration Commissioner Scott Gottlieb is stepping down after nearly two years leading the agency

WASHINGTON (AP) — Food and Drug Administration Commissioner Scott Gottlieb is stepping down after nearly two years leading the agency. </s> (CNN) US Food and Drug Administration Commissioner Dr. Scott Gottlieb said in a letter to staff Tuesday that he will be leaving the agency.

"It's is hard for me to write this note to share with you the news that I'll be leaving my job as the Commissioner of Food and Drugs in the next month. There's perhaps nothing that could pull me away from this role other than the challenge of being apart from my family for these past two years and missing my wife and three young children," says the letter, which the FDA tweeted

An administration official familiar with the situation said the move has been in the works for several months. Gottlieb has been commuting weekly to Washington from his home in Connecticut and is leaving to spend more time with his family, the official said.

Gottlieb tweeted that he is "grateful for the opportunity to help lead this wonderful agency."

I'm immensely grateful for the opportunity to help lead this wonderful agency, for the support of my colleagues, for the public health goals we advanced together, and the strong support of @SecAzar and @realDonaldTrump - This has been a wonderful journey and parting is very hard. https://t.co/1Zu9y7NTwR — Scott Gottlieb, M.D. (@SGottliebFDA) March 5, 2019

Gottlieb previously served as the agency's deputy commissioner for medical and scientific affairs. After he was appointed by President Donald Trump, he was sworn in as the 23rd commissioner on May 11, 2017.

Read More </s> Chuck Rosenberg, acting head of the Drug Enforcement Administration, will resign on Oct. 1, multiple media outlets are reporting.

Rosenberg, a holdover from President Barack Obama’s administration, announced on Tuesday he would be stepping down in an email sent to the DEA staff, according to The Washington Post. </s> President Donald Trump said Trump he has accepted the resignation of Environmental Protection Agency Administrator Scott Pruitt.

“I have accepted the resignation of Scott Pruitt as the Administrator of the Environmental Protection Agency. Within the Agency Scott has done an outstanding job, and I will always be thankful to him for this. The Senate confirmed Deputy at EPA, Andrew Wheeler, will on Monday assume duties as the acting Administrator of the EPA. I have no doubt that Andy will continue on with our great and lasting EPA agenda. We have made tremendous progress and the future of the EPA is very bright!” Trump tweeted Thursday.

Pruitt has found himself at odds with Iowa’s entire Congressional delegation due to his actions to undermine the Renewable Fuel Standard. Senator Charles Grassley had said in recent months he was close to calling for Pruitt’s resignation. </s> WASHINGTON (CBSMiami) – Scott Pruitt, the controversial Environmental Protection Agency Administrator, is out of a job.

I have accepted the resignation of Scott Pruitt as the Administrator of the Environmental Protection Agency. Within the Agency Scott has done an outstanding job, and I will always be thankful to him for this. The Senate confirmed Deputy at EPA, Andrew Wheeler, will…

Andrew Wheeler, the Deputy Aministrator of the EPA, will take over for Pruitt beginning on Monday.

This is a developing story and will be updated. </s> Dr. Brenda Fitzgerald has resigned as Director of the Centers for Disease Control and Prevention, the U.S. Department of Health and Human Services announced Wednesday.

The news comes after a report that she bought shares in a tobacco company one month after taking over an agency tasked with working to stop people from smoking, according to CNN. Politico had the initial report on the stock purchase.

"Dr. Fitzgerald owns certain complex financial interests that have imposed a broad recusal limiting her ability to complete all of her duties as the CDC Director," the HHS statement reads. "Due to the nature of these financial interests, Dr. Fitzgerald could not divest from them in a definitive time period." </s> The acting chief of the US Drug Enforcement Administration, who has been critical of US President Donald Trump, is stepping down at the end of the week, a spokeswoman said Wednesday.

Chuck Rosenberg, who was known to be close to fired former FBI director James Comey, has resigned "effective October 1," spokeswoman Katherine Pfaff told AFP.

Rosenberg is a holdover from former president Barack Obama's administration, and Trump had been expected to name his own person to head the agency.

But Rosenberg, a former prosecutor who has led the DEA on an interim basis since 2015, had also been at odds with the president.

After Trump publicly suggested in July that the police not treat suspects with kid gloves, Rosenberg sent an internal email to DEA colleagues criticizing the president as having "condoned police misconduct."

"We have an obligation to speak out when something is wrong," Rosenberg said. </s> Brenda Fitzgerald, director of the Centers for Disease Control and Prevention, is stepping down. This follows reports that she invested in tobacco company stocks after she began leading the agency.
United States' Food and Drug Administration commissioner Scott Gottlieb announces his resignation "in the next month".